Empagliflozin in cystic fibrosis related diabetes (ANZCTR) - Sep 18, 2026 - P3/4 | N=45 | Recruiting | Sponsor: Western Sydney Local Health District | Not yet recruiting ➔ Recruiting | N=20 ➔ 45 | Initiation date: Aug 2026
Enrollment change • Enrollment open • Trial initiation date • Cystic Fibrosis • Diabetes • Genetic Disorders • Immunology • Metabolic Disorders • Pulmonary Disease • Respiratory Diseases
|